ConvaTec Group (OTCMKTS:CNVVY) Price Target Raised to GBX 225

ConvaTec Group (OTCMKTS:CNVVYGet Rating) had its target price upped by Credit Suisse Group from GBX 220 ($2.74) to GBX 225 ($2.80) in a research report released on Tuesday, The Fly reports.

A number of other research analysts have also recently weighed in on the company. Barclays lifted their target price on ConvaTec Group from GBX 295 ($3.67) to GBX 300 ($3.73) in a report on Friday, May 19th. Sanford C. Bernstein initiated coverage on ConvaTec Group in a research note on Tuesday, March 7th. They issued an outperform rating on the stock. Finally, JPMorgan Chase & Co. boosted their price target on ConvaTec Group from GBX 281 ($3.50) to GBX 305 ($3.79) in a research note on Friday, March 10th. One analyst has rated the stock with a hold rating and four have assigned a buy rating to the stock. According to, the stock presently has an average rating of Moderate Buy and an average target price of $266.25.

ConvaTec Group Price Performance

ConvaTec Group stock opened at $10.69 on Tuesday. The stock has a fifty day moving average of $10.72 and a two-hundred day moving average of $11.03. ConvaTec Group has a fifty-two week low of $8.69 and a fifty-two week high of $12.23.

ConvaTec Group Increases Dividend

The company also recently announced a dividend, which will be paid on Friday, June 9th. Shareholders of record on Tuesday, April 11th will be given a $0.1396 dividend. This represents a yield of 1.85%. This is an increase from ConvaTec Group’s previous dividend of $0.05. The ex-dividend date of this dividend is Monday, April 10th.

ConvaTec Group Company Profile

(Get Rating)

ConvaTec Group Plc operates as holding company, which engages in medical business. Its activities include development, manufacture and sales of medical products and technologies related to therapies for the management of chronic conditions, including products used for advanced chronic and acute wound care, ostomy care and management, continence and critical care, and infusion devices used in the treatment of diabetes and other conditions.

Recommended Stories

The Fly logo

Analyst Recommendations for ConvaTec Group (OTCMKTS:CNVVY)

Receive News & Ratings for ConvaTec Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConvaTec Group and related companies with's FREE daily email newsletter.